In October of 2015, North Carolina man Earl Groce was diagnosed with stage 4 pancreatic cancer. Five years later, this month, he rang the cancer ward’s victory bell to mark a survival milestone.
He is among only 3 percent of pancreatic cancer patients to make it this far.
“Thank you all,” he says through tears. “Y'all are wonderful.”
That very same day, Groce also underwent his 116th chemotherapy treatment.
His daughter, a surgical oncologist, connected Groce with experts at Wake Forest’s Comprehensive Cancer Center, leading him to enroll in a personalized clinical trial.
Groce has tolerated chemotherapy well for five years, which “isn’t typical” for pancreatic cancer patients, according to his doctor. “[M]ost patients have a much shorter survival,” Yacoub said, “but ... it has provided him with more time and maintained his quality of life.”
Wake Forest Baptist’s Comprehensive Cancer Center is one of only 51 National Cancer Institute (NCI)-designated centers in the United States. Case studies have shown that NCI-designated cancer centers can improve long-term survival rates by up to 25 percent.
Groce’s story is one of hope for both himself and for others.
Very few people with his same diagnosis, Groce reflected, make it to where he is today. “I owe that to my wonderful healthcare providers, my clinical trial, and family and friends who have supported and encouraged me,” he said.